Regeneus Ltd. (AU:CMB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cambium Bio Limited has announced the appointment of Chi-Tai Chang as a director on October 10, 2024. Following this appointment, it was disclosed that Chang has an indirect interest in the company through 2,384,359 ordinary shares held by Cyntec Co., Ltd, where he serves as a director. No direct holdings were reported, and no interests in contracts were disclosed.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.